Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126926411 | 12692641 | 1 | I | 20160125 | 20160816 | 20160829 | 20160829 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-068296 | BRISTOL MYERS SQUIBB | 60.16 | YR | F | Y | 0.00000 | 20160829 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126926411 | 12692641 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 12 MG, QD | Y | 9218 | 12 | MG | TABLET | QD | |||||
| 126926411 | 12692641 | 2 | SS | COUMADINE | WARFARIN SODIUM | 1 | Unknown | 10 MG, QD | Y | 9218 | 10 | MG | TABLET | QD | |||||
| 126926411 | 12692641 | 3 | C | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 2 DF, QD | U | 0 | 2 | DF | QD | ||||||
| 126926411 | 12692641 | 4 | C | AMIKACINE /00391001/ | AMIKACIN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 126926411 | 12692641 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 126926411 | 12692641 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 126926411 | 12692641 | 7 | C | CALCIDIA | CALCIUM POLYCARBOPHIL | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 126926411 | 12692641 | 8 | C | CERAZETTE /00754001/ | DESOGESTREL | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 126926411 | 12692641 | 9 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 1200 MG, TID | U | 0 | 1200 | MG | TID | ||||||
| 126926411 | 12692641 | 10 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | Oral | 2 DF, QD | U | 0 | 2 | DF | TABLET | QD | |||||
| 126926411 | 12692641 | 11 | C | IMOVANE | ZOPICLONE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 126926411 | 12692641 | 12 | C | IMUREL /00001501/ | AZATHIOPRINE SODIUM | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 126926411 | 12692641 | 13 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 3 DF, QD | U | 0 | 3 | DF | TABLET | QD | |||||
| 126926411 | 12692641 | 14 | C | LESCOL | FLUVASTATIN SODIUM | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | CAPSULE | QD | |||||
| 126926411 | 12692641 | 15 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 126926411 | 12692641 | 16 | C | NEORAL | CYCLOSPORINE | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | CAPSULE, SOFT | BID | |||||
| 126926411 | 12692641 | 17 | C | SULFARLEM | ANETHOLTRITHION | 1 | Oral | 2 DF, QD | U | 0 | 2 | DF | QD | ||||||
| 126926411 | 12692641 | 18 | C | TEMESTA /00273201/ | LORAZEPAM | 1 | Oral | 3 DF, QD | U | 0 | 3 | DF | TABLET | QD | |||||
| 126926411 | 12692641 | 19 | C | TENORMIN | ATENOLOL | 1 | Oral | 3 DF, QD | U | 0 | 3 | DF | FILM-COATED TABLET | QD | |||||
| 126926411 | 12692641 | 20 | C | UN-ALFA | ALFACALCIDOL | 1 | Oral | 0.5 ?G, QD | U | 0 | .5 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126926411 | 12692641 | 1 | Product used for unknown indication |
| 126926411 | 12692641 | 3 | Antibiotic therapy |
| 126926411 | 12692641 | 4 | Antibiotic therapy |
| 126926411 | 12692641 | 5 | Product used for unknown indication |
| 126926411 | 12692641 | 7 | Product used for unknown indication |
| 126926411 | 12692641 | 8 | Product used for unknown indication |
| 126926411 | 12692641 | 9 | Product used for unknown indication |
| 126926411 | 12692641 | 10 | Product used for unknown indication |
| 126926411 | 12692641 | 11 | Product used for unknown indication |
| 126926411 | 12692641 | 12 | Product used for unknown indication |
| 126926411 | 12692641 | 13 | Product used for unknown indication |
| 126926411 | 12692641 | 14 | Product used for unknown indication |
| 126926411 | 12692641 | 15 | Product used for unknown indication |
| 126926411 | 12692641 | 16 | Product used for unknown indication |
| 126926411 | 12692641 | 17 | Product used for unknown indication |
| 126926411 | 12692641 | 18 | Product used for unknown indication |
| 126926411 | 12692641 | 19 | Product used for unknown indication |
| 126926411 | 12692641 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126926411 | 12692641 | OT |
| 126926411 | 12692641 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126926411 | 12692641 | Escherichia sepsis | |
| 126926411 | 12692641 | International normalised ratio increased | |
| 126926411 | 12692641 | Klebsiella test positive | |
| 126926411 | 12692641 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126926411 | 12692641 | 1 | 20160127 | 0 | ||
| 126926411 | 12692641 | 2 | 20160203 | 0 | ||
| 126926411 | 12692641 | 3 | 20160125 | 20160127 | 0 | |
| 126926411 | 12692641 | 4 | 20160125 | 0 |